Patient-derived induced pluripotent stem cell organoids for amyotrophic lateral sclerosis drug discovery

https://www.scienceopen.com/hosted-document?doi=10.15212/AMM-2024-0077

Announcing a new publication for Acta Materia Medica journal. Complex biological mechanisms and unidentified therapeutic targets for amyotrophic lateral sclerosis (ALS) significantly hinder the development of effective treatments. Given these challenges, reliable disease models that accurately replicate ALS phenotypes with relevant biological underpinnings are essential for advancing precision medicine in ALS. Patient-derived induced pluripotent stem cell (iPSC) organoids have emerged as an innovative tool for disease modeling and drug evaluation. Growing evidence highlights the advantages of organoids in replicating ALS phenotypes and supporting drug development. However, challenges remain in utilizing organoids for ALS drug testing and other neurodegenerative diseases. In this review the current progress in ALS model development are summarized, encompassing both in vitro and in vivo non-human models, as well as iPSC-derived human models. Furthermore, within the context of ALS drug screening, critical considerations for applying organoids to evaluate disease-associated phenotypes and to accurately reflect disease-related symptoms are discussed.

# # # # # #

Acta Materia Medica welcomes the submission of research articles, review articles, databases, mini reviews, commentaries, editorials, short communications, case report articles and study protocols.

Submission Process

Submissions to Acta Materia Medica are made using ScholarOne, the online submission and peer review system. Registration and access are available at https://mc04.manuscriptcentral.com/ammed

Queries about the journal can be sent to editorialoffice@amm-journal.org.

Please visit https://amm-journal.org/ to learn more about the journal.

Editorial Board: https://amm-journal.org/index.php/editorial-board/

There are no author submission or article processing fees.

Follow Acta Materia Medica on Twitter https://twitter.com/AMM_journal; Facebook (https://www.facebook.com/AMMjournal)

eISSN 2737-7946

# # # # # #

Wenyan Li, Jinqi Liu and Wenting Li et al. Patient-derived induced pluripotent stem cell organoids for amyotrophic lateral sclerosis drug discovery. Acta Materia Medica. 2025. Vol. 3(4):556-570. DOI: 10.15212/AMM-2024-0077